Open AccessSuccessful treatment of plasma exchange-refractory thrombotic thrombocytopenic purpura with rituximab: A case report
Author(s) -
Jian Chen,
Jingxia Jin,
Xiaofei Xu,
Xuanxuan Zhang,
Xingg Ye,
Jian Huang
Publication year - 2020
Publication title -
world journal of clinical cases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.368
H-Index - 10
ISSN - 2307-8960
DOI - 10.12998/wjcc.v8.i12.2617
Subject(s) - medicine , adamts13 , thrombotic thrombocytopenic purpura , rituximab , thrombotic microangiopathy , refractory (planetary science) , platelet , gastroenterology , case fatality rate , surgery , disease , epidemiology , physics , lymphoma , astrobiology
Thrombotic thrombocytopenic purpura (TTP), a subtype of thrombotic microangiopathy, has a very high fatality rate if there is no timely diagnosis or treatment. Here, we report a case of TTP refractory to high displacement plasma exchange, which was later successfully treated with rituximab.